Plaque neutralization assays were carried out using the rhabdoviruses of pike fry (2 isolates), spring viraemia of carp and grass carp. When rabbit anti-pike fry rhabdovirus sera were used, no neutralizing activity was observed but plaque counts increased with heat-inactivated sera or sera that had been stored at -2o °C for prolonged periods. Antibody binding to the virus was demonstrated by gradient centrifugation experiments. The use of immune serum alone or in combination with anti-rabbit gamma globulin serum resulted in aggregation of radioactive virus. Aggregation was also observed when anti-rabbit gamma globulin serum was added under neutralization test conditions. Addition of non-inactivated guinea-pig serum to mixtures of pike fry rhabdovirus and rabbit antiserum to spring viraemia of carp virus resulted in strong neutralization, whereas this antiserum alone or in the presence of inactivated guinea-pig serum gave an increase in plaque numbers. The increase in plaque number and the complementdependent neutralization phenomena were weak or absent in the homologous spring viraemia of carp virus system.
INTRODUCTION
The identification of fish rhabdoviruses by conventional neutralization tests is often hampered by the difficulty of producing potent antisera against these viruses in rabbits (de Kinkelin et al. 1974; Hill et al. 1975 , Roy et al. 1975 . In the homologous virus-antiserum system only moderate or low neutralizing activity was reported for pike fry rhabdovirus (PFR) whereas satisfactory activities were obtained with spring viraemia of carp virus (SVCV; de Kinkelin & Le Berre, 1974; Hill et al. I975; Roy et al. 1975) . In heterologous neutralization tests these viruses were shown to be distinct as suggested earlier (de Kinkelin et al. I973; Kinkelin et al. I974; Hill et al. I975; Roy et al. 1975) . However, minor cross reactivity does occur (Hill et al. I975) . The present study was conducted to refine the neutralization tests for the identification of PFR since it was previously demonstrated that the lack of neutralizing activity could not be attributed to the absence of antiviral antibodies in rabbit anti-PFR sera (Clerx & Horzinek, 3[978) . METHODS Viruses and cells. The reference strain of PFR (de Kinkelin et al. I973) , the V 75/94 isolate of PFR (Clerx & Horzinek, 1978) grass carp rhabdovirus (GRV; Ahne, ~975), and SVCV (Fijan et al. I97I) were grown in fathead minnow (FHM) cells as described previously (de Kinkelin et al. 1974; Clerx et al. 1975) . Viruses were plaque purified before they were used for immunization or in neutralization assays.
Antisera
Rabbit sera. Two random bred rabbits were immunized by interdigital (first immunization), subcutaneous and intramuscular injections of FHM-grown purified PFR emulsified with Freund's complete (first immunization) or incomplete adjuvant. Each rabbit received o'a5 to o'4 mg of either infectious (rabbit ooI) or o I % formaldehyde fixed virus (rabbit oo4). A total of ten immunizations at intervals of 4 to 8 weeks was performed before final bleeding 2 weeks after the last injections. During the course of immunization, blood samples were taken before each booster injection. The interim sera were assayed for plaque neutralizing activity either after <~ 2 days at 4 °C, or after storage at -7 ° °C for not more than 5 weeks.
Rabbit anti-SVCV serum was a gift from Dr C. Pfeil, Grub, West Germany. It had been prepared in New Zealand white rabbits by eight intravenous injections at weekly intervals of io r to Io 9 TCIDs0 units of SVCV grown in FHM cells under serum-free culture medium. Two further injections were given at week II and 3[7 (2"5)< 3[09 and 4 x 3[07 TCIDs0 units, respectively) before final bleeding at week 2o. The serum was heat-inactivated (3o min at 56 °C) before use.
Pike sera. Three pike (Esox lucius L., 3[758) of 55 to 7o cm total length were kept in an inflatable swimming pool in running tap water at temperatures between 15 and 23[ °C (mean temperature 18 °C). Before immunization and bleeding, the animals were anaesthetized with M5-222 (Sandoz Ltd., Basle, Switzerland). Each pike received either o.1 to o'5 mg of purified PFR or 0"5 ml of a suspension of PFR-infected cells (~ ~o suspension of fractured cells). No adjuvants were used. Injections were given intraperitoneally on days o, 3 [0, 2o, 29, 36, 48, 62, II8, I36, 3[57 and I83[. Sera were harvested on days 62, 157 and 3[83[ respectively. Blood was withdrawn from the artery leading to the posterior gill arch using a ~9 or 2o gauge needle fitted to a syringe. Blood volumes withdrawn corresponded to 0'5 to 2 % of body weight. After centrifugation for 3o min at ~2oog, serum was harvested, subdivided and stored at -7o °C until used. The goat anti-rabbit gamma globulin serum (GAR) used in the double antibody neutralization tests and centrifugation experiments was purchased from Nordic Diagnostics, Tilburg, The Netherlands. It was stored at 4 °C and heat inactivated before use.
Neutralization assays. Virus dilutions were prepared in tris-buffered Eagle's MEM (pH 7"4) containing 2 % foetal bovine serum. Equal parts of the virus dilutions (containing ~oo to 400 p.f.u./ml) and serial serum dilutions in phosphate buffered saline (PBS, pH 7"0 to 7"3) were mixed and incubated at 2o °C for 60 min unless otherwise stated. One volume of virus dilution with an equal volume of PBS served as a control. Confluent FHM monolayers in 6 cm Petri dishes were inoculated with o'5 ml of the mixtures. A minimum of 3 dishes per dilution was used. After 6o rain of adsorption at IO to I4 °C, the inoculum was removed and the cells were overlaid with tris-buffered MEM containing 3 % foetal bovine serum and o-6% agarose (de Kinkelin et al. I974) . The dishes were incubated for 42 to 48 h at 2o °C, stained with neutral red and further incubated for up to 3 days in order to increase the size of the small plaques.
Double antibody tests. Virus-anti-PFR serum mixtures were incubated for 6o rain, GAR was added (in amounts stated in the legends to Fig. I and 3 ) and the tubes incubated at 20 °C for an additional 6o min. Virus without rabbit antiserum and with or without ~o% GAR served as controls. Neutralization kinetics. To study the kinetics of virus neutralization, samples of the virusantiserum mixtures were taken at o, 5, lO, I5, 30 and 60 min after mixing and assayed immediately. Alternatively, a tenfold excess of GAR over rabbit serum was added to the virus-antiserum mixture at different times and incubated further for 6o rain before inoculation.
Complement-dependent neutralization. Guinea-pig serum stored at -7o °C for several months served as a source of complement. Virus-antiserum mixtures which had been incubated for 6o rain were supplemented with I/5 vol. of guinea-pig serum and incubated at 2o °C for an additional 3o rain. Controls without antiserum received either inactivated (3o rain at 56 °C) or uninactivated guinea-pig serum. Standard errors of mean plaque numbers per dish (s.e. mean) were calculated according to standard procedures. Gradient centrifugation. 3H-uridine or ~H-amino acid labelled PFR (Clerx et al. 1975) in TES buffer (o. I M-NaCI, I mM-EDTA, o-oz M-tris-HC1, pH 7'4) was mixed with rabbit or pike serum dilutions in PBS and incubated at 20 °C for 3o to 45 rain. Samples of o.1 ml (5 x io s to 5 x io 9 p.f.u.) were layered on to isokinetic sucrose gradients (van der Zeijst & Bloemers, I976) in TES buffer and centrifuged at 5 °C (for details see legend to Fig. 6 ).
Gel filtration of pike serum proteins. Immunoglobulins were precipitated as follows:
3"45 ml of one immune serum was precipitated three times with ammonium sulphate at a final concentration of 1.8 M at 4 °C. Pellets were dissolved in column buffer (I .o M-NaC1, o.I M-tris-HC1, pH 8.o) and dialysed overnight at 4 °C. Proteins were fractionated at room temperature on a 35 x 2"5 cm Sephadex G-2oo column at a flow rate of I5 ml/h. One ml fractions were collected and stored at 4 °C until use. Fractions over the whole range of the gel were diluted I : 4 with sterile water before testing for virus neutralizing activity. Diluted sterile column buffer served as a control.
RESULTS

Neutralization assays using rabbit sera
Although all viruses could be propagated efficiently in BHK cells, only SVCV produced visible plaques (Clark & Soriano, 1974) . Therefore titrations were performed on FHM monolayers. The plaque numbers of all viruses could be increased either by washing the monolayers with DEAE-dextran containing buffers, or by dilution of virus inocula in these buffers, the latter method being more efficient (de Kinkelin et al. I974; our unpublished observations). All neutralization tests were performed without DEAE-dextran to avoid possible effects on virus-antibody interactions.
Both uninactivated and inactivated (3o rain at 56 °C) pre-inoculation sera from two rabbits (designated ooI and oo 4 in Table I and 
* Plaque numbers are expressed as percentage of control plaque number. was obtained at 0"95% serum ooi concentration and I ~o serum 004 concentration (Table 2) . Eight months after bleeding Ouchterlony double diffusion tests were carried out with serum oor. Heavy precipitation lines with PFR as antigen were observed, indicating the presence of antibody. Further tests showed that appreciable amounts of antibodies had been induced against all virus proteins (Clerx & Horzinek, I978) . The neutralization titres, however, dropped further until no neutralizing activity could be detected after storage at -20 °C for 8 months (Table 2) . On the contrary, both sera produced a concentrationdependent increase of plaque numbers under neutralization test conditions. Inactivation of the immune sera further increased the plaque number (compare the upper curves in Fig. I --stored II months, non-inactivated -and Fig. 2 -stored t2 months, inactivated -in which the concentration dependency is apparent). Enhanced plaque formation was invariably accompanied by an increase in the number of plaques of a smaller size (diam. ~< I mm after 72 h as compared to standard sized plaques which measure/> 2 mm after 48 h).
As can be seen in Table 3 , the relative increase is dependent on the concentration of immune serum and is also observed with the heterologous viruses (SVCV only in Table 3 ). The effect of the immune serum on the plaque size was shown to be phenotypic: 5 small and 5 standard sized plaque clones of PFR split up in identical small to standard size ratios Attempts to detect antigenic differences between the viruses by neutralization kinetics using non-inactivated sera were unsuccessful. When samples of the virus-immune serum mixtures were withdrawn at intervals and immediately applied to monolayers, no increased reduction could be detected between incubation times of 5 to 6o rain. Samples from the virus-immune serum mixtures supplemented with a m-fold excess of GAR over rabbit serum also showed the same plaque counts between 5 and 6o rain of incubation time. 
Evidence for virus-antibody interaction
After the addition of GAR to virus-immune serum mixtures, a substantial decrease in plaque counts of PFR was noted, as shown in Fig. ~ (lower curve) . This observation was also made with V 75/94, GRV and SVCV (insert to Fig. I ). Pre-inoculation sera with a tenfold excess of GAR over rabbit serum did not show reduction of plaque counts nor did GAR alone.
Evidence that antibody rather than any other serum component had bound to the virion surface and GAR had produced plaque reduction by the formation of virus-antibody aggregates came from an earlier experiment. In this experiment PFR and serial dilutions of non-inactivated rabbit serum (stored 5 months) were supplemented with a constant amount of GAR. As can be seen in Fig. 3 , the highest plaque numbers were found at o.z % rabbit serum where the ratio GAR : rabbit serum approached unity. With lower rabbit serum concentrations, or higher ratios of GAR over rabbit serum, the plaque numbers decreased rapidly, indicating aggregation. It can be concluded that immune serum concentrations as low as o.o2 % contain detectable amounts of antiviral antibodies. Further evidence came from gradient centrifugation experiments. Using concentrated purified PFR, complete precipitation of radioactive label occurred with immune serum concentrations of 1% or more. Using GAR at a tenfold excess, complete precipitation was observed with immune serum concentrations down to o.2 %. This would imply a sedimentation coefficient 
Complement-dependent neutralization
Addition of non-inactivated guinea-pig serum to virus-immune serum mixtures caused a pronounced decrease in plaque counts. Using anti-PFR serum this decrease was observed to about the same degree with all four viruses (Fig. z for PFR and SVCV) ; mixtures containing inactivated guinea-pig serum served as controls. The latter showed a plaque enhancement which was more pronounced in the PFR-anti-PFR than in the SVCV-anti-PFR mixtures (upper curves in Fig. 2) . Complement-dependent 5o % plaque reduction endpoints were calculated for concentrations ofo'oI5 % for PFR and o'o7 % for SVCV using immune serum ooi.
A similar complement-dependent neutralization was found for PFR using rabbit anti-SVCV serum. In the homologous SVCV-anti-SVCV system, however, complement had only a moderate effect on the neutralization of SVCV (Table 4 ). Inactivated guinea-pig serum in the absence of specific antibody usually showed less virus neutralization than non-inactivated serum ( Table 4 ). The degree of virus neutralization by guinea-pig serum varied between different batches.
Neutralization assays using pike sera
The neutralization data for sera from three pike are given in Table z . The pre-inoculation sera showed substantial plaque reduction when tested at a Io% concentration (Fig. 4) . The virus neutralizing activity of pike serum did not increase further after six injections of antigen in pike 3 and nine injections in pike I and 2 (Table z) . Final bleedings were performed 3oi days after the last immunization. These sera showed the same neutralization titres as did sera collected 2o5 days before. This indicates that neutralizing activity in pike serum remains stable over a long time.
GRV and the V 75/94 isolate of PFR were found to be indistinguishable from the PFR reference strain with the two sera tested; Fig. 4 shows an experiment comparing the neutralization of PFR and GRV by pike immune serum. A moderate reduction in SVCV plaque counts was observed with the pre-inoculation sera (Fig. 4) . However, at certain concentrations of immune serum we invariably found higher plaque counts than for untreated SVCV inocula (Fig. 4) .
Gel filtration of pike serum proteins on Sephadex G-2oo revealed that the virus neutralizing activity eluted in the void volume ( Fig. 5) . SDS-polyacrylamide electrophoresis on slab gels (Clerx & Horzinek, I978) of the column fractions showed the presence of heavy and light immunoglobulin chains (apparent mol. wt. approx. 70 ooo and 22 ooo respectively) in fractions 45 to 65, reaching a maximum in fraction 53-The neutralizing activity clearly paralleled the quantities of heavy and light chains in the fractions.
Gradient centrifugation
To study the effect of pike antibodies on PFR, rate zonal centrifugation was performed with labelled virus. Ten % pre-inoculation serum did not cause any change in virus sedimentation. A 1% concentration of the first immune serum from pike 3 showed a pronounced effect: the main peak of radioactivity was found at a position corresponding to about 64oS, a second peak at 845S and a small amount of label accumulated at the bottom of the tube (Fig. 6 ). With higher serum concentrations complete precipitation occurred. The increased sedimentation rate of 64oS suggests attachment of antibody molecules to virus particles whereas the small peak at 845S probably consists of virus dimers bridged by antibody molecules.
DISCUSSION
Complement factors probably play an important role in the neutralization of PFR by rabbit immune sera since the neutralizing activity decreased after prolonged storage or inactivation; virus neutralizing capacity could be enhanced by addition of non-inactivated but not_by addition of inactivated guinea-pig serum. The phenomenon is well documented for other enveloped animal viruses, e.g. togaviruses, herpesviruses and coronaviruses (Ashe & Notkins, I967; Almeida & Waterson, I969; Horzinek, ~973)-Recently, lysis of vesicular stomatitis virus by non-inactivated human serum in the apparent absence of specific antibody has been described (Mills et al. 2976) . In contrast to this observation, inactivation of fish rhabdoviruses by fresh guinea-pig serum is only moderate: non-inactivated guinea-pig serum showed a batch-dependent reduction in plaque counts which reached 5o% (at I7 % final concentration) in some experiments (Table 4 ). Both PFR and SVCV were neutralized to about the same extent by anti-PFR serum in the presence of uninactivated guinea-pig serum, and the PFR-anti-SVCV reaction also resulted in neutralization. In the homologous SVCV system, however, only minor differences were observed between reaction mixtures supplemented with non-inactivated and inactivated guinea-pig serum (Table 4 ). Similar observations have been made by de Kinkelin & Le Berre (~974) using anti-SVCV serum supplemented with non-inactivated normal rabbit serum.
Plaque enhancement using rabbit immune sera closely followed the patterns of complement-dependent neutralization; as can be seen in Table 4 only anti-SVCV serum failed to increase the plaque number of the homologous virus. Since pre-inoculation sera had no effect, antibodies are believed to be the cause of this peculiar phenomenon. Binding of homologous and heterologous antibody to the virus surface has been demonstrated by treating the virus-antiserum mixtures with GAR which resulted in virus aggregation ( Fig. ~ and 3) and altered sedimentation patterns of the homologous PFR system in sucrose gradients (not shown). The occurrence of neutralization after addition of complement further supports this assumption. It therefore seems that the virus not only remains infectious after binding with antibodies but that it also infects the cell with a higher efficiency. Since pre-treatment of the cells with rabbit anti-PFR serum had no effect on the plaque numbers, we assume that virus-antibody complexes are more readily adsorbed to the cell surface than virus alone. Possibly a mechanism analogous to that seen with DEAE-dextran treated virus could be responsible for this peculiar phenomenon. The concomitant increase in small plaques, however, cannot be explained by an improved adsorption; it suggests a retardation of virus penetration into the cell (Della-Porta & Westaway, I978). The plaque enhancement phenomenon was absent when BHK-2I grown PFR and SVCV were used in standard neutralization tests on FHM cells (our unpublished observations); host cellular functions (e.g. glycosyl-transferases) probably play a role in antibody recognition. However, using anti-PFR serum we were unable to demonstrate antibodies reacting with the SVCV glycoprotein under immuncelectrophoresis conditions (Clerx & Horzinek, I978) .
In contrast to the results obtained with rabbit immune sera, regular neutralization of PFR was observed using pike anti-PFR sera (Table 2, Fig. 4 ). Heating of pike serum had no effect on the neutralization reaction. Gel filtration experiments showed that the neutralizing activity was confined to high tool. wt. antibody. It has been identified as a tetrameric molecule (J. P. M. Clerx et al., unpublished data) . Neutralization data obtained with V 75/94 and GRV show their close relationship to the original PFR isolate: these viruses are neutralized to the same degree as PFR ( Fig. 4 for GRV). Clear differences, however, are obtained with SVCV. The increasing neutralization of SVCV during the course of immunization (while PFR neutralization titres remain unaltered) suggests a decreasing specificity and/or an increased avidity of the antibodies. We do not know if the enhanced plaque formation of SVCV by certain concentrations of pike anti-PFR sera and the enhanced plaque formation observed with rabbit immune sera are caused by similar mechanisms.
